Use of capecitabine in refractory metastatic medullary thyroid carcinoma.
Paiva
Carlos Eduardo
CE
Michelin
Odair Carlito
OC
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000069287:Capecitabine; D018276:Carcinoma, Medullary / Q000188:drug therapy* / Q000601:surgery; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil